# Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

> **NCT05618600** · — · COMPLETED · sponsor: **Scripps Translational Science Institute** · enrollment: 917 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05618600
- **Lead sponsor:** Scripps Translational Science Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-04
- **Primary completion:** 2023-12-08
- **Final completion:** 2024-06-10
- **Target enrollment:** 917 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618600, "Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05618600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*